As a journalist for The New Yorker, Mark Singer has written extensively about the GOP’s presidential nominee.
Recently he gave a talk about his new book, Trump and Me, published earlier this month, where he answered questions about his reporting from an audience. In the hour-long talk held at Politics & Prose Bookstore in Washington, D.C. and published Wednesday, Singer discusses his take on the presidential nominee based on his work writing profiles about Trump for the New Yorker.
Singer said he believed Trump never expected to make it this far in the election, and was hoping to wind up second behind one of the other primary candidates. He said he is not into “details” and probably had no plans to actually be president.
“Would a person who really wants to be elected run without a staff, without a ground game state-to-state, without a fundraising network, without any regard for policy nuances, no concept of governance and all the other things that one does to prepare,” Singer said. “Can you imagine Trump debating Hillary Clinton?”
“I think his greatest fear is losing, period,” Singer said. “I think he’s at best very conflicted about it.”
When asked by moderator and fellow New Yorker staff writer Jane Mayer why Trump would put himself in this position, Singer answered it was ego-driven.
“His ego is — there’s nothing like it really,” Singer said. “We’ve never witnessed anyone like this in public life. I mean, people compare Trump to P.T. Barnum, but P.T. Barnum was promoting other acts and things like this, and he has been promoting himself. There is no real Donald Trump. There is ‘Donald Trump.’ He is his brand… He’s predicated his whole existence on leveraging his name, Donald Trump, and everything that he’s ever done, I thought, has been calculated as an extension of the brand. He’s not a details person plainly.”
Singer then referenced a piece by Stephanie Cegielski, a former public relations staffer who defected and now claims Trump didn’t intend to become the Republican nominee.
“The Trump camp would have been satisfied to see him polling at 12% and taking second place to a candidate who might hold 50%. His candidacy was a protest candidacy,” she wrote. “It pains me to say, but he is the presidential equivalent of Sanjaya on American Idol.”
Singer agreed with Mayer that Trump is now stuck — but “he just wants to hear his name shouted from the public, and he responds to it.”
Watch the entire talk, as posted to YouTube, here:
What is China doing to stop Beijing’s new coronavirus outbreak?
Over 1,000 flights have been cancelled, schools shut and residents urged not to leave Beijing, as Chinese authorities race to contain a fresh outbreak linked to the capital's largest wholesale food market.
The number of confirmed cases in the capital has shot up to 137 within the last week after two months of no cases, and four other provinces have revealed cases linked to the Beijing cluster.
How did the outbreak begin, and what measures are Beijing taking to contain it?
- What is the origin of the cluster? -
Beijing had turned into a virtual fortress at the height of the pandemic, with people arriving from other regions or countries required to undergo quarantines.
Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report
According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.
The report, by the Times' Reid Epstein, begins with one such possible scenario.
‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint
Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.